Skip to main content

Find Clinical Trials

Home
Conditions
Communicable Diseases

Clinical trial condition

Communicable Diseases

Explore clinical trials studying Communicable Diseases. Study availability and eligibility vary by location and protocol.

9,172 public trials 550 recruiting studies

Refine in advanced search Browse all conditions

Communicable Diseases trial results

Completed

Safety and Efficacy of Albumin Interferon Administered Every 4 Weeks in Genotype 2/3 Hepatitis C Patients

NCT00759200

Conditions: Blood-Borne Infections, Chronic Disease, Chronic Hepatitis C, +15 more
Locations: Novartis Investigative site Clayton, Australia

Novartis Investigative site Fitzroy, Australia

Novartis Investigative site Greenslopes, Australia

Novartis Investigative site Kingswood, Australia

View all 55 locations

View Trial Details

Completed

Differences in Evoked Intracellular Interferon Signaling Pathways Using Single Cell Phosphoprotein Profiling

NCT01217359

Conditions: Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +8 more
Locations: University of North Carolina Chapel Hill, North Carolina, United States

View Trial Details

Completed

The Safety and Immunogenicity of the DNA-GTU Vaccine Administered to HIV-infected Patients on ART vs Placebo

NCT02457689

Conditions: Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +14 more
Locations: Imperial College London Greater London, United Kingdom

View Trial Details

Completed

Tenofovir Disoproxil Fumarate vs. Entecavir in Chronic Hepatitis B Patients With Partial Virologic Response to Entecavir

NCT01711567

Conditions: Blood-Borne Infections, Chronic Disease, Chronic Hepatitis B, +15 more
Locations: Korea University Ansan Hospital Ansan, Gyeonggi-do, South Korea

View Trial Details

Completed

Phase I Trial of an Intervention to Increase Condom Use by HIV-Discordant Couples

NCT00000928

Conditions: Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations: Not specified

View Trial Details

Completed

A Study of Zidovudine in the Prevention of HIV Infection in Individuals Exposed to the Virus

NCT00000993

Conditions: Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +13 more
Locations: Glaxo Wellcome Inc Research Triangle Park, North Carolina, United States

View Trial Details

Completed

A Study of HIV in Newly Infected Individuals

NCT00000930

Conditions: Behavior, Blood-Borne Infections, Chemically-Induced Disorders, +24 more
Locations: Los Angeles County / Health Research Assoc / Drew Med Ctr Los Angeles, California, United States

San Francisco Dept of Hlth / AIDS Office San Francisco, California, United States

Denver Dept of Public Health / HIVNET Denver, Colorado, United States

Univ of Illinois Chicago / Howard Brown Hlth Ctr Chicago, Illinois, United States

View Trial Details

Completed

Immunogenicity and Safety of a DTPa-HBV-IPV/Hib Vaccine Given at 2, 3 and 4 Months of Age

NCT00376779

Conditions: Acellular Pertussis, Actinomycetales Infections, Bacterial Infections, +32 more
Locations: GSK Investigational Site Jarvenpaa, Finland

GSK Investigational Site Oulu, Finland

GSK Investigational Site Pori, Finland

GSK Investigational Site Tampere, Finland

View Trial Details

Completed

A Study to Evaluate the Immunogenicity and Safety of GSK Biologicals' HPV Vaccine in Healthy Women Aged 18-35 Years

NCT00306241

Conditions: Communicable Diseases, DNA Virus Infections, Disease Attributes, +22 more
Locations: GSK Investigational Site Hong Kong

View Trial Details

Completed

Follow-up Study of GSK Biologicals' Human Papilloma Virus (HPV) Vaccine to Prevent Cervical Infection in Young Adults

NCT00120848

Conditions: Communicable Diseases, DNA Virus Infections, Disease Attributes, +11 more
Locations: GSK Investigational Site San Francisco, California, United States

GSK Investigational Site San Francisco, California, United States

GSK Investigational Site Augusta, Georgia, United States

GSK Investigational Site Bardstown, Kentucky, United States

View all 27 locations

View Trial Details